Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$274.90 USD

274.90
1,518,178

+3.90 (1.44%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $275.00 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (228 out of 244)

Industry: Medical - HMOs

Zacks News

Zacks Equity Research

Zacks.com featured highlights include: Allison Transmission, Cigna, Celanese and Stryker

Zacks.com featured highlights include: Allison Transmission, Cigna, Celanese and Stryker

Zacks Equity Research

4 GARP Stocks for a Winning Portfolio

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

Zacks Equity Research

Marsh & McLennan's Arm Acquires Otis-Magie Insurance Agency

Marsh & McLennan's (MMC) subsidiary purchases Otis-Magie Insurance Agency to enrich customer experience in northern Minnesota.

Zacks Equity Research

MGIC Investment Reports Solid November Insurance in Force

MGIC Investment's (MTG) solid November 2018 operating business statistics reflects improved business as well as housing market fundamentals.

Zacks Equity Research

AIG Slips to 52 Week Low: Will the Stock Decline Further?

Shares of American International Group (AIG) hit a 52-week low on Dec 7 due to its catastrophe loss forecast and weak revenues.

Zacks Equity Research

Hartford Financial Provides Q4 Catastrophe Loss Estimates

Hartford Financial (HIG) announces fourth-quarter current accident year after-tax impact of $275-$290 million.

Zacks Equity Research

Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?

Is (CI) Outperforming Other Finance Stocks This Year?

Zacks Equity Research

What Falling Estimates & Price Mean for American International Group (AIG)

American International Group (AIG) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

Zacks Equity Research

Marsh & McLennan's (MMC) Unit Closes Pavilion Acquisition

Marsh & McLennan's (MMC) arm wraps up the pending purchase of Pavilion to enrich customer experiences.

Zacks Equity Research

6 Solid Reasons to Invest in MetLife for Portfolio Growth

Backed by a solid capital management and business rejig, MetLife (MET) holds great prospects to reap returns for investors.

Sapna Bagaria headshot

HMO Industry Surges Almost 4 Times S&P 500: 4 Picks

Health insurers gains on strong industry and operating conditions, the same should continue in 2019.

Zacks Equity Research

Cigna (CI) Gains But Lags Market: What You Should Know

Cigna (CI) closed at $224.84 in the latest trading session, marking a +0.65% move from the prior day.

Zacks Equity Research

Why Is Cigna (CI) Up 3.3% Since Last Earnings Report?

Cigna (CI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

American International's (AIG) New Subsidiaries Get Ratings

American International's (AIG) units receive rating actions from Moody's. The rating outlook remains stable.

Zacks Equity Research

Aon Issues Unsecured Notes, Gets Rating Actions From Moody's

Aon (AON) issued senior unsecured notes get rating affirmations from Moody's. Outlook remains stable.

Zacks Equity Research

Zacks.com highlights: Cigna, Celanese, O'Reilly Automotive and S&T Bancorp

Zacks.com highlights: Cigna, Celanese, O'Reilly Automotive and S&T Bancorp

Zacks Equity Research

4 GARP Stocks to Scoop Up for Maximum Returns

If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

Zacks Equity Research

7 Solid Reasons Why Cigna is a Must Add to Your Portfolio

Backed by a solid third-quarter performance, strong Global Healthcare segment and burgeoning membership, Cigna (CI) holds great potential for yield-seeking investors.

Zacks Equity Research

Marsh & McLennan Unit Buyout to Offer Better Client Services

Marsh & McLennan's (MMC) arm Mercer wraps up the acquisition of Summit Strategies Group to boost customer relations.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for November 21st

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

Zacks Equity Research

Is Cigna (CI) Stock Outpacing Its Finance Peers This Year?

Is (CI) Outperforming Other Finance Stocks This Year?

Zacks Equity Research

Marsh & McLennan's Arm Sets Up Digital Broker Platform

Marsh & McLennan's (MMC) unit unveils a cloud-based digital broker platform called Bluestream.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Cigna, Progressive, James River and American Equity

The Zacks Analyst Blog Highlights: Cigna, Progressive, James River and American Equity

Zacks Equity Research

Near-Term Outlook for Health Maintenance Organization Industry

Retiring baby boomer population, new streams of revenues and consolidation paint a bright picture for the HMO industry.

Zacks Equity Research

Marsh & McLennan (MMC) to Launch Specialty Business

Marsh & McLennan (MMC) to launch a new specialty business named Marsh-JLT Specialty. The same is pending closure of the Jardine Lloyd Thompson Group's acquisition.